Stem Cell Research (Apr 2023)

Generation of an induced pluripotent stem cell line from a Huntington’s disease patient with a long HTT-PolyQ sequence

  • Duncan C. Miller,
  • Pawel Lisowski,
  • Carolin Genehr,
  • Erich E. Wanker,
  • Josef Priller,
  • Alessandro Prigione,
  • Sebastian Diecke

Journal volume & issue
Vol. 68
p. 103056

Abstract

Read online

Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by an abnormal length of CAG repeats in the gene HTT, leading to an elongated poly-glutamine (poly-Q) sequence in huntingtin (HTT). We used non-integrative Sendai virus to reprogram fibroblasts from a patient with juvenile onset HD to induced pluripotent stem cells (iPSCs). Reprogrammed iPSCs expressed pluripotency-associated markers, exhibited a normal karyotype, and following directed differentiation generated cell types belonging to the three germ layers. PCR analysis and sequencing confirmed the HD patient-derived iPSC line had one normal HTT allele and one with elongated CAG repeats, equivalent to ≥180Q.